Lead Sponsor

Genzyme, a Sanofi Company

Age

16 - No limit years

Sex

ALL

Healthy Volunteers

No

•Patients must have successfully completed the previous double-blind study AGAL-008-00 (NCT00074984)
•Patients must provide written informed consent prior to study participation
•Female patients of childbearing potential must have a negative pregnancy test prior to each dosing and all female patients must use a medically accepted form of contraception throughout the study

•The patient was unable to complete AGAL-008-00 (NCT00074984)
•The patient has undergone kidney transplantation or is currently on dialysis
•The patient has diabetes mellitus or presence of confounding renal disease
•The patient has a clinically significant organic disease or an unstable condition that precludes participation
•The patient is unwilling to comply with the protocol requirements